Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | EYA2 | O00167 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10388977 | 0.93 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL78691 | 0.91 | CA14 (0.41) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL5916355 | 0.90 | CA14 (0.43) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL22852725 | 0.90 | CA14 (0.43) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL1677637 | 0.90 | CA12 (0.40) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL11521511 | 0.89 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL10786935 | 0.89 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL18631244 | 0.89 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL16280777 | 0.88 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2TDP1 | |
| SCHEMBL19339624 | 0.87 | CA14 (0.38) | CA14HDAC6HDAC1HDAC2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1699491-B1 | BRANCHED POLYETHYLENE GLYCOL FOR LINKING POLYMER RESIDUES TO ANTIBODIES | UCB PHARMA SA (BE) | 2011-11-16 | — | — | EP | disclosed |
| US-7736635-B2 | Branched molecular scaffolds for linking polymer residues to biologically active moieties | UCB PHARMA S.A. (BE) | 2010-06-15 | — | — | US | disclosed |
| US-20070128150-A1 | Branched molecular scaffolds for linking polymer residues to biologically active moieties | UCB BIOPHARMA SPRL (BE) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070128150-A1 | Branched molecular scaffolds for linking polymer residues to biologically active moieties | ILK, ECPAS, FGB | CA14 1343/4885HDAC6 1096/4885HDAC1 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.